Australian and New Zealand Journal of Obstetrics and Gynaecology

Editorial
pp. 73-73(1)

Advice has changed for hormone therapy in the WHI era
pp. 74-76(3)

Endogenous anti-oxidants in pregnancy and preeclampsia
pp. 77-83(7)
Author: PERKINS, Anthony V.

Hormone therapy in the WHI era
pp. 84-91(8)
Author: BURGER, Henry G.

Antenatal screening for Down syndrome in New Zealand: Time for a national screening policy?
pp. 92-96(5)
Author: CHANG, Tou Choong

Maternal serum activin A and the prediction of intrauterine growth restriction
pp. 97-101(5)
Authors: BARKEHALL-THOMAS, Andrea; TONG, Stephen; BAKER, Lesleigh S.; EDWARDS, Andrew; WALLACE, Euan M.

Subcutaneous sterile water injection for labour pain: A randomised controlled trial
pp. 102-106(5)
Authors: BAHASADRI, Shohreh; AHMADI-ABHARI, Sara; DEHGHANI-NIK, Mojghan; HABIBI, Gholam Reza

A medical management of interstitial ectopic pregnancy: A 5-year clinical study
pp. 107-111(5)
Authors: TANG, Amy; BAARTZ, David; KHOO, Soo Keat

Guidelines following hydatidiform mole: A reappraisal
pp. 112-118(7)
Authors: WIESMA, Sabien; KERKMEIJER, Linda; BEKKERS, Ruud; PYMAN, Jan; TAN, Jeffrey; QUINN, Michael

Persistent trophoblast disease following partial molar pregnancy
pp. 119-123(5)
Authors: WIESMA, Sabien; KERKMEIJER, Linda; BEKKERS, Ruud; PYMAN, Jan; TAN, Jeffrey; QUINN, Michael

Vacuum-assisted delivery: An analysis of traction force and maternal and neonatal outcomes
pp. 124-127(4)
Author: VACCA, Aldo

Postmenopausal hormone therapy: Who now takes it and do they differ from non-users?
pp. 128-135(8)
Authors: TAYLOR, Anne W.; MACLENNAN, Alastair H.; AVERY, Jodie C.

Effect of inhaled glucocorticoid treatment on placental 11β-hydroxysteroid dehydrogenase type 2 activity and neonatal birthweight in pregnancies complicated by asthma
pp. 136-140(5)
Authors: CLIFTON, Vicki L.; RENNIE, Natascha; MURPHY, Vanessa E.

No more surrogate end-points in randomised trials: The PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomiphene
pp. 141-145(5)
Author: JOHNSON, Neil Philip

Activin A, hypoxia and the prediction of obstetric outcomes
pp. 146-147(2)
Author: TONG, Stephen

Activin-A secretion is increased in the eutopic endometrium from women with essndometriosis
pp. 148-153(6)
Authors: ROMBAUTS, Luk; DONOGHUE, Jacqui; CANN, Leonie; JONES, Rebecca L.; HEALY, David L.

Molecular profiling of human endometrium during the menstrual cycle
pp. 154-158(5)
Authors: PONNAMPALAM, Anna P.; WESTON, Gareth C.; SUSIL, Beatrice; ROGERS, Peter A. W.

A possible role for progesterone metabolites in human parturition
pp. 159-163(5)
Author: SHEEHAN, Penelope M.

Do women with polycystic ovary syndrome really have predisposition to atherosclerosis?
pp. 164-167(4)
Authors: TOPCU, Semra; CALISKAN, Mustafa; GULLU, Hakan; OZCIMEN, Emel Ebru; ERDOGAN, Dogan; UCKUYU, Ayla; ZEYNELOGLU, Hulusi; MUDERRISOGLU, Haldun

Successful pregnancy in a woman with glycogen storage disease type III
pp. 168-169(2)
Authors: BHATTI, Shazia; PARRY, Emma

Re: Effects of rosiglitazone on hormonal profile and ovulatory function in Chinese women with polycystic ovary syndrome
pp. 170-171(2)

Re: Comparison of cerebral magnetic resonance and electroencephalogram findings in preeclamptic and eclamptic women
pp. 171-171(1)

Authors' reply
pp. 171-172(2)

Re: Factors associated with low immunity to rubella infection on antenatal screening
pp. 172-172(1)

Re: Customised fetal weight: Centile charts or tables?
pp. 172-173(2)

Authors' reply
pp. 173-174(2)

Re: Midurethral Tissue Fixation System sling – a `micromethod' for cure of stress incontinence – preliminary report and Tissue Fixation System posterior sling for repair of uterine/vault prolapse – a preliminary report
pp. 174-174(1)

Authors' reply
pp. 174-175(2)

Editor's comment
pp. 175-175(1)

Re: Total reconstruction
pp. 175-176(2)

Authors' reply
pp. 176-176(1)

Re: Tissue Fixation System (TFS)
pp. 176-177(2)

Re: Midurethral Tissue Fixation System (TFS)
pp. 177-178(2)